Catherine M. Engelbert is Director of Royalty Pharma plc. Currently has a direct ownership of 43,514 shares of RPRX, which is worth approximately $1.15 Million. The most recent transaction as insider was on Jun 07, 2024, when has been sold 9,293 shares (Class A Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.5K
0% 3M change
31.02% 12M change
Total Value Held $1.15 Million

Catherine M. Engelbert Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 07 2024
BUY
Grant, award, or other acquisition
-
9,293 Added 17.6%
43,514 Class A Ordinary Shares
Jun 23 2023
BUY
Grant, award, or other acquisition
-
7,747 Added 18.91%
33,211 Class A Ordinary Shares
Jun 24 2022
BUY
Grant, award, or other acquisition
-
6,328 Added 19.9%
25,464 Class A Ordinary Shares
Jun 25 2021
BUY
Grant, award, or other acquisition
-
5,726 Added 23.03%
19,136 Class A Ordinary Shares
Sep 30 2020
BUY
Grant, award, or other acquisition
$37,465 $41.17 p/Share
910 Added 6.35%
13,410 Class A Ordinary Shares

Also insider at

MCD
MCDONALDS CORP Consumer Cyclical
CME

Catherine M. Engelbert

Director
Chicago, IL

Track Institutional and Insider Activities on RPRX

Follow Royalty Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPRX shares.

Notify only if

Insider Trading

Get notified when an Royalty Pharma PLC insider buys or sells RPRX shares.

Notify only if

News

Receive news related to Royalty Pharma plc

Track Activities on RPRX